FutureDx Summit 2026 · Companion Diagnostics Conference
Companion Diagnostics Conference 2026: FutureDx Summit, London
FutureDx Summit 2026 is a two-day companion diagnostics conference in London, bringing together 150+ NHS pathology, genomics and oncology decision-makers with the companies developing companion diagnostic and biomarker tests.
P.S. This is the diagnostics side of precision medicine. See the precision medicine conference overview.
We reply personally, usually within one working day.
FutureDx Summit is a UK companion diagnostics (CDx) conference, held on 27–28 October 2026 in London, UK.
| Event | FutureDx Summit 2026 |
|---|---|
| Focus | Companion diagnostics and molecular diagnostics |
| Dates | 27–28 October 2026 (two days) |
| Location | London, United Kingdom |
| Format | In-person conference, exhibition and pre-arranged 1:1 meetings |
| Who attends | 150+ NHS and industry diagnostics decision-makers |
| Organiser | FutureDx Summit |
Who should attend
- Consultant Pathologistsmolecular and cellular pathology
- NHS Genomics Leadsgenomic medicine services
- Oncology & CDx Specialistscancer diagnostics pathways
- Clinical Scientistsmolecular diagnostics
- Laboratory Directorspathology and molecular services
- Diagnostics & Pharma Teamscompanion diagnostics and biomarkers
Frequently asked questions
Is there a companion diagnostics conference in the UK in 2026?
Yes. FutureDx Summit is a UK companion diagnostics (CDx) conference held on 27–28 October 2026 in London. It covers companion diagnostics, biomarkers and the molecular tests that guide targeted therapy, with 150+ NHS and industry decision-makers.
What is companion diagnostics?
A companion diagnostic (CDx) is a test that identifies which patients are likely to benefit from a specific therapy, by detecting a biomarker. Companion diagnostics is a core theme at FutureDx Summit 2026, spanning oncology, molecular pathology and precision medicine.
When and where is FutureDx Summit 2026?
FutureDx Summit 2026 takes place on 27–28 October 2026 in London, UK, as a two-day in-person conference.
Who should attend a companion diagnostics conference?
The programme suits consultant pathologists, NHS genomics leads, oncology and CDx specialists, clinical scientists and laboratory directors, alongside the diagnostics and pharma companies developing companion diagnostic tests.
At a glance
Where Companion Tests Meet the NHS
A focused two-day summit in London, built around molecular and infectious disease diagnostics, with a drinks reception on Day 1.
Who it is for
Built for the Test Side of Companion Diagnostics
If your companion diagnostic needs an NHS lab to run it and clinicians to trust it, those people are in this room.
Companion Diagnostic Developers
Tests that pair a therapy with the right patient.
Biomarker Companies
From research marker to actionable test.
Pharma Rx-Dx and CDx Teams
Programmes that need NHS test adoption.
Molecular and Genomic Test Makers
The platforms companion tests run on.
Resistance-Guided Therapy
Infection companion testing that guides the drug.
AI and Data in Biomarkers
Interpretation that turns signal into a decision.
The commercial reality
The Road to Routine NHS Use
A companion diagnostic does not earn revenue when it is approved. It earns revenue when the NHS runs it routinely. This is the road, and the people who decide each step are here.
Evidence
The data that proves the test works.
Lab Validation
It runs reliably in the NHS lab.
Clinical Confidence
Clinicians trust and act on the result.
Routine Adoption
The test becomes standard practice.
Every step is an NHS decision. FutureDx puts you in front of the lab and clinical leaders who make them, in pre-arranged meetings.
Why sponsor
Why Companion Diagnostics Companies Sponsor FutureDx
Your science is only as commercial as its adoption. FutureDx puts you in front of the people who decide.
A Focused Room
Diagnostics buyers, not a general healthcare crowd.
Pre-Arranged Meetings
Confirmed time with the buyers who adopt tests.
Validated Buyers
Decision-makers vetted before they register.
Measurable Return
A spend tied to meetings you can count and report.
The field
Where Companion Diagnostics Fits
These are the areas the room works across. Explore the ones that match, or the wider precision medicine conference.
Precision Medicine
The right treatment for the right patient.
Explore precision →Molecular Diagnostics
The platforms companion tests run on.
Explore molecular →Genomics and NGS
Sequencing-led biomarker testing.
Explore genomics →Companion Testing in AMR
Resistance-guided therapy for infection.
Explore AMR Rx-Dx →Pharmacogenomics
Testing that guides drug choice and dosing.
Biomarker Discovery
From research marker to routine test.
Resistance-Guided Therapy
The infection companion-testing angle.
Host-Response Testing
Reading the patient, not just the pathogen.
The room
Who You Will Meet
A companion diagnostic scales only once the NHS adopts it. These are the people who make that call.
Delegate Seniority
The Buyers Who Adopt the Test
To be clear about fit: the room is senior NHS laboratory, genomics, microbiology, and infection leaders, the people who decide which tests get adopted, not a pharma or oncology therapeutics audience. If your companion diagnostic needs NHS adoption, this is your room. Reach them through the 1:1 meetings programme or a sponsorship package.
Ways to take part
How to Sponsor, Exhibit, or Meet Buyers
Choose the level of presence that fits your goals. Every option includes pre-arranged meetings.
Sponsorship Packages →
From Gold to Headline, with branding, speaking, and meetings.
1:1 Meetings Programme →
Up to 20 pre-arranged meetings with validated buyers.
Exhibit →
A stand on a small, curated, senior floor.
Cost Per Lead →
See the maths behind the meetings.
The pack
Get the Sponsor and Exhibitor Pack
Everything to Make the Call
- The full audience and seniority breakdown
- Sponsorship and exhibitor packages, side by side
- How the pre-arranged meeting model works
- Pricing and what is included at each level
- A simple ROI framework for your board
Sent by a person, with a conversation.
Questions
Companion Diagnostics Conference FAQs
Is FutureDx a companion diagnostics conference?
FutureDx is a molecular diagnostics summit with an infectious disease focus. A companion diagnostic is, at its core, a test, and this is where tests meet the NHS labs and clinicians who adopt them. It is a strong fit if your companion diagnostic needs UK lab adoption, especially in molecular and infectious disease testing. You will meet senior diagnostics, laboratory, genomics, and infection buyers, not a pharma or oncology therapeutics audience.
When and where is it held?
FutureDx Summit 2026 runs across two days on 27 and 28 October 2026 in London, UK, with a drinks reception on Day 1.
Who will we meet?
150 plus senior diagnostics professionals from across the UK, more than 60% at VP level and above, every one validated as a decision-maker or procurement influencer before they register, including laboratory, genomics, microbiology, and infection leaders who decide which tests the NHS adopts.
Does companion diagnostics apply in infectious disease?
Yes. Resistance-guided therapy is companion testing in all but name: the test determines which antimicrobial a patient should receive. That makes FutureDx, with its infectious disease and molecular focus, a natural home for companion testing as well as the wider precision medicine field.
Why sponsor FutureDx if you work in companion diagnostics?
Because a companion diagnostic only earns revenue once the NHS runs it routinely, and that decision sits with labs and clinical leaders. FutureDx puts you in pre-arranged meetings with exactly those buyers, with a return you can measure rather than a stand in a crowd.
What sponsorship and exhibitor options are available?
Options range from exhibiting to headline sponsorship, plus a standalone 1:1 Meetings programme. Each package includes a set number of pre-arranged meetings with validated buyers. Request the sponsor and exhibitor pack for the full breakdown and pricing.
How many meetings can we get?
It depends on your package: pre-arranged meetings range from 6 with Gold to 15 with Headline, or up to 20 with the standalone 1:1 Meetings programme. Each is a confirmed conversation with a validated NHS buyer.
It is the inaugural edition. Is it worth sponsoring?
The room is capped and validated, and your spend is tied to confirmed meetings rather than the gamble of footfall, which keeps it low-risk. Sponsoring the first edition also gives you first-mover visibility with the UK diagnostics community.
Take part
Put the Test Side of Your CDx in the Room
Send your details and a senior member of the team replies with the sponsor and exhibitor pack and builds a plan around the lab and clinical buyers you most want to reach.
- Pre-arranged meetings with 150 plus validated buyers
- The NHS people who decide on test adoption
- A reply from a person, not an autoresponder
P.S. Want the wider field first? See precision medicine or molecular diagnostics.
The Companion Diagnostics Conference UK Buyers Attend
Does FutureDx cover cancer diagnostics?
FutureDx Summit 2026 covers cancer diagnostics as a cancer diagnostics conference theme, spanning companion diagnostics, molecular oncology and biomarker testing. London, 27–28 October 2026.
Is there a companion diagnostics conference in the UK in 2026?
Yes. FutureDx Summit is a companion diagnostics conference in the UK, held on 27–28 October 2026 in London, covering CDx, biomarkers and molecular oncology for 150+ NHS and industry buyers.